Zhaoxu Li

Mr. Zhaoxu Li

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2022 in Molecules
Verified
Journal Article
Open access
PDF file
RLRuyue Luo
Ruyue Luo
YWYuan Wan
Yuan Wan
XLXinyi Luo
Xinyi Luo
GLGuicen Liu
Guicen Liu
ZLZhaoxu Li
Zhaoxu Li
ZLZhongli Luo
Zhongli Luo
Self-assembly peptide nanotechnology has attracted much attention due to its regular and orderly structure and diverse functions. Most of the existing self-assembly peptides can form aggregates with specific structures only under specific conditions and their assembly time is relatively long. They have good biocompatibility but no immunogenicity. To optimize it, a self-assembly peptide named DRF3 was designed. It contains a hydrophilic and hydrophobic surface, using two N-terminal arginines, leucine, and two c-terminal aspartate and glutamic acid. Meanwhile, the c-terminal of the peptide was amidated, so that peptide segments were interconnected to increase diversity. Its characterization, biocompatibility, controlled release effect on antigen, immune cell recruitment ability, and antitumor properties were examined here. Congo red/aniline blue staining revealed that peptide hydrogel DRF3 could be immediately gelled in PBS. The stable β-sheet secondary structure of DRF3 was confirmed by circular dichroism spectrum and IR spectra. The observation results of cryo-scanning electron microscopy, transmission electron microscopy, and atomic force microscopy demonstrated that DRF3 formed nanotubule-like and vesicular structures in PBS, and these structures interlaced with each other to form ordered three-dimensional nanofiber structures. Meanwhile, DRF3 showed excellent biocompatibility, could sustainably and slowly release antigens, recruit dendritic cells and promote the maturation of dendritic cells (DCs) in vitro. In addition, DRF3 has a strong inhibitory effect on clear renal cell carcinoma (786-0). These results provide a reliable basis for the application of peptide hydrogels in biomedical and preclinical trials.

24 April 2026 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
LZLilian Zeinalvand
Lilian Zeinalvand
DBDipankar Barpuzary
Dipankar Barpuzary
TUTae Hyun Ueon
Tae Hyun Ueon
WLWalter B. Lai
Walter B. Lai
YSYuanming Song
Yuanming Song
JPJoseph Patterson
Joseph Patterson

12 May 2025 in Chemphyschem
Verified
Journal Article
Closed access
YSYuanming Song
Yuanming Song
ZLZhaoxu Li
Zhaoxu Li
JMJustin T. Mulvey
Justin T. Mulvey
JFJ. Alfredo Freites
J. Alfredo Freites
JPJoseph Patterson
Joseph Patterson
DTDouglas J. Tobias
Douglas J. Tobias

20 March 2026 in Chemistry of Materials
Verified
Journal Article
Closed access
BRBen Rose
Ben Rose
EOElisa M. Olivas
Elisa M. Olivas
PPPushp Raj Prasad
Pushp Raj Prasad
ZLZhaoxu Li
Zhaoxu Li
FWFangni Wang
Fangni Wang
JPJoseph Patterson
Joseph Patterson